Position in VERA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,197,180
+$2,975,915 QoQ
Shares Held
74,509
+1254.7% QoQ
Ownership
0.103%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#80
of 217 holders
Holding Since
Sep 2023
9 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in VERA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. VERA ranks #112 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in VERA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,197,180 | 74,509 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $221,265 | 5,500 | Shares | Defined | 2026-05-15 | |
| 2025-06-30 | $357,028 | 15,154 | Shares | Defined | 2025-08-14 | |
| 2024-12-31 | $3,149,590 | 74,476 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,766,597 | 130,466 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $13,411,383 | 370,685 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $25,916,672 | 601,036 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,230,399 | 210,039 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,168,730 | 158,186 | Shares | Defined | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||